← Back to Search

Synthetic Tissue Substitute

CorNeat EverPatch for Glaucoma

N/A
Waitlist Available
Research Sponsored by CorNeat Vision Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female
Aged ≥ 18 and ≤ 80 years on screening day
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Study Summary

This trial is designed to demonstrate the safety of the CorNeat EverPatch for concealment of artificial implants and glaucoma tube shunts. The study will enroll 10 subjects who will be monitored for a period of 12 months.

Eligible Conditions
  • Glaucoma
  • Tissue Necrosis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of treatment-related adverse events
Secondary outcome measures
Conjunctival integrity
Stability in patch dimensions

Trial Design

1Treatment groups
Experimental Treatment
Group I: Synthetic Tissue SubstituteExperimental Treatment1 Intervention
Corneat EverPatch - Synthetic Tissue Substitute for Covering Ophthalmic Implants

Find a Location

Who is running the clinical trial?

CorNeat Vision Ltd.Lead Sponsor
3 Previous Clinical Trials
110 Total Patients Enrolled
1 Trials studying Glaucoma
60 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who would be the most ideal participants for this research endeavor?

"This clinical trial is now attempting to recruit 10 people with glaucoma who are between the ages of 18 and 80. Additional eligibility requirements include being male or female, possessing functional tear film and lids, having visual acuity of light perception or better, as well as using an effective contraceptive throughout the duration of their participation in the study. Furthermore, participants must be willing to attend all scheduled visits and comply with all procedures set forth by this research team."

Answered by AI

Are there any restrictions on this clinical investigation based upon age?

"In accordance with the conditions set forth, this clinical trial seeks participants aged 18-80."

Answered by AI

Are there still patient slots available for this experiment?

"Clinicaltrials.gov reveals that this clinical trial, which was made available on December 11th 2020 and most recently updated on April 17th 2022, is no longer actively seeking participants. Nevertheless, there are 206 other studies presently enrolling patients."

Answered by AI
~7 spots leftby Mar 2025